# A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma

> **NCT01044966** · PHASE1,PHASE2 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 12 (actual)

## Conditions studied

- Glioblastoma Multiforme
- Glioma
- Astrocytoma
- Brain Tumor

## Interventions

- **DRUG:** ITV DepoCyt + Temozolomide

## Key facts

- **NCT ID:** NCT01044966
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2013-08
- **Final completion:** 2014-09
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** The study was terminated due to lack of adequate patient enrollment into trial.
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01044966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01044966, "A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01044966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*